These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21671028)

  • 61. Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
    Mannucci PM; Lombardi R; Lattuada A; Ruggenenti P; Viganò GL; Barbui T; Remuzzi G
    Blood; 1989 Aug; 74(3):978-83. PubMed ID: 2665869
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS).
    Moake JL
    Prog Clin Biol Res; 1990; 337():135-40. PubMed ID: 2191307
    [No Abstract]   [Full Text] [Related]  

  • 63. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes.
    Kojouri K; Vesely SK; George JN
    Ann Intern Med; 2001 Dec; 135(12):1047-51. PubMed ID: 11747383
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases.
    Hosler GA; Cusumano AM; Hutchins GM
    Arch Pathol Lab Med; 2003 Jul; 127(7):834-9. PubMed ID: 12823037
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pathological aspects of membranoproliferative glomerulonephritis (MPGN) and haemolytic uraemic syndrome (HUS) / thrombocytic thrombopenic purpura (TTP).
    Benz K; Amann K
    Thromb Haemost; 2009 Feb; 101(2):265-70. PubMed ID: 19190808
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pathogenesis of thrombotic microangiopathies.
    Zheng XL; Sadler JE
    Annu Rev Pathol; 2008; 3():249-77. PubMed ID: 18215115
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Baker KR; Moake JL
    Curr Opin Pediatr; 2000 Feb; 12(1):23-8. PubMed ID: 10676770
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies.
    Trojnar E; Józsi M; Szabó Z; Réti M; Farkas P; Kelen K; Reusz GS; Szabó AJ; Garam N; Mikes B; Sinkovits G; Mező B; Csuka D; Prohászka Z
    Front Immunol; 2019; 10():240. PubMed ID: 30858847
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lupus nephritis combined with renal injury due to thrombotic thrombocytopaenic purpura-haemolytic uraemic syndrome.
    Yu F; Tan Y; Zhao MH
    Nephrol Dial Transplant; 2010 Jan; 25(1):145-52. PubMed ID: 19703836
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13.
    Chapman K; Seldon M; Richards R
    Semin Thromb Hemost; 2012 Feb; 38(1):47-54. PubMed ID: 22314603
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Thrombotic microangiopathies: an update.
    Franchini M
    Hematology; 2006 Jun; 11(3):139-46. PubMed ID: 17325953
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies.
    Cataland SR; Wu HM
    Eur J Intern Med; 2013 Sep; 24(6):486-91. PubMed ID: 23739653
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategies.
    Mayer SA; Aledort LM
    Mt Sinai J Med; 2005 May; 72(3):166-75. PubMed ID: 15915311
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Platelets: thrombotic thrombocytopenic purpura.
    George JN; Sadler JE; Lämmle B
    Hematology Am Soc Hematol Educ Program; 2002; ():315-34. PubMed ID: 12446430
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Controversies in differentiating thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Shah NT; Rand JH
    Mt Sinai J Med; 2003 Oct; 70(5):344-51. PubMed ID: 14631521
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Elliott MA; Nichols WL
    Mayo Clin Proc; 2001 Nov; 76(11):1154-62. PubMed ID: 11702904
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
    Clark WF
    Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
    [TBL] [Abstract][Full Text] [Related]  

  • 79. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
    Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
    Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Review of thrombotic microangiopathy (TMA), and post-renal transplant TMA.
    Ardalan MR
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):235-44. PubMed ID: 16903637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.